Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients

ABSTRACT Objective To evaluate melatonin secretion in adult hypopituitary patients with Growth Hormone deficiency (AGHD) on and off replacement therapy. Subjects and methods We studied 48 subjects: 12 (6 males) untreated AGHD (AGHDnt), 20 (10 males) treated AGHD (AGHDt) and 16 healthy subjects (...

Full description

Bibliographic Details
Main Authors: Hugo L. Fideleff, Gabriel Fideleff, Hugo R. Boquete, Martha Suárez, Miriam Azaretzky
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2016-02-01
Series:Archives of Endocrinology and Metabolism
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972016000300223&lng=en&tlng=en
id doaj-9e20b79600f54c068713274de2509d16
record_format Article
spelling doaj-9e20b79600f54c068713274de2509d162020-11-25T01:31:21ZengBrazilian Society of Endocrinology and MetabolismArchives of Endocrinology and Metabolism2359-42922016-02-0160322323010.1590/2359-3997000000153S2359-39972016000300223Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patientsHugo L. FideleffGabriel FideleffHugo R. BoqueteMartha SuárezMiriam AzaretzkyABSTRACT Objective To evaluate melatonin secretion in adult hypopituitary patients with Growth Hormone deficiency (AGHD) on and off replacement therapy. Subjects and methods We studied 48 subjects: 12 (6 males) untreated AGHD (AGHDnt), 20 (10 males) treated AGHD (AGHDt) and 16 healthy subjects (8 males) as control group (CG). We measured urinary 6-sulfatoxymelatonin (6-SM) in total (24 h samples), nocturnal (6-SMn): 1800-0800 and diurnal samples (6-SMd): 0800-1800. Results Significant differences were observed among the 3 groups of male subjects, in total 6-SM (p < 0.05), nocturnal 6-SM (p < 0.02) and nighttime-daytime delta values (p < 0.003). CG had significantly higher values than the AGHDnt in total 6-SM (p < 0.01), nocturnal 6-SM (p < 0.05) and nighttime-daytime delta values (p < 0.01). AGHDt patients showed significantly higher levels in nighttime-daytime delta values than AGHDnt patients (p < 0.05). In females, no significant differences were found among the 3 groups studied in total, nocturnal, diurnal or nighttime-daytime delta values. In males, significant correlations were found among total 6-SM (r = 0.58; p = 0.029), nocturnal 6-SM (r = 0.70; p = 0.006) and nighttime-daytime delta values (r = 0.71; p = 0.004) vs. serum IGF-1 levels in subjects evaluated. In females, significant correlations were found among total 6-SM (r = 0.57; p = 0.02) vs. serum IGF-1 levels in subjects evaluated. A tendency towards a significant correlation was found in diurnal 6-SM (r = 0.48; p = 0.07). Conclusions Our findings show a sexual dimorphism in 6-SM excretion in AGHD patients and provide an interesting approach to a further understanding of some chronobiological disorders involved in GH deficiency.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972016000300223&lng=en&tlng=en6-sulphatoxymelatoninmelatonin and GHadult GH deficiencygrowth hormone treatmentmelatonin and sexual dimorphism
collection DOAJ
language English
format Article
sources DOAJ
author Hugo L. Fideleff
Gabriel Fideleff
Hugo R. Boquete
Martha Suárez
Miriam Azaretzky
spellingShingle Hugo L. Fideleff
Gabriel Fideleff
Hugo R. Boquete
Martha Suárez
Miriam Azaretzky
Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
Archives of Endocrinology and Metabolism
6-sulphatoxymelatonin
melatonin and GH
adult GH deficiency
growth hormone treatment
melatonin and sexual dimorphism
author_facet Hugo L. Fideleff
Gabriel Fideleff
Hugo R. Boquete
Martha Suárez
Miriam Azaretzky
author_sort Hugo L. Fideleff
title Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
title_short Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
title_full Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
title_fullStr Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
title_full_unstemmed Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
title_sort male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
publisher Brazilian Society of Endocrinology and Metabolism
series Archives of Endocrinology and Metabolism
issn 2359-4292
publishDate 2016-02-01
description ABSTRACT Objective To evaluate melatonin secretion in adult hypopituitary patients with Growth Hormone deficiency (AGHD) on and off replacement therapy. Subjects and methods We studied 48 subjects: 12 (6 males) untreated AGHD (AGHDnt), 20 (10 males) treated AGHD (AGHDt) and 16 healthy subjects (8 males) as control group (CG). We measured urinary 6-sulfatoxymelatonin (6-SM) in total (24 h samples), nocturnal (6-SMn): 1800-0800 and diurnal samples (6-SMd): 0800-1800. Results Significant differences were observed among the 3 groups of male subjects, in total 6-SM (p < 0.05), nocturnal 6-SM (p < 0.02) and nighttime-daytime delta values (p < 0.003). CG had significantly higher values than the AGHDnt in total 6-SM (p < 0.01), nocturnal 6-SM (p < 0.05) and nighttime-daytime delta values (p < 0.01). AGHDt patients showed significantly higher levels in nighttime-daytime delta values than AGHDnt patients (p < 0.05). In females, no significant differences were found among the 3 groups studied in total, nocturnal, diurnal or nighttime-daytime delta values. In males, significant correlations were found among total 6-SM (r = 0.58; p = 0.029), nocturnal 6-SM (r = 0.70; p = 0.006) and nighttime-daytime delta values (r = 0.71; p = 0.004) vs. serum IGF-1 levels in subjects evaluated. In females, significant correlations were found among total 6-SM (r = 0.57; p = 0.02) vs. serum IGF-1 levels in subjects evaluated. A tendency towards a significant correlation was found in diurnal 6-SM (r = 0.48; p = 0.07). Conclusions Our findings show a sexual dimorphism in 6-SM excretion in AGHD patients and provide an interesting approach to a further understanding of some chronobiological disorders involved in GH deficiency.
topic 6-sulphatoxymelatonin
melatonin and GH
adult GH deficiency
growth hormone treatment
melatonin and sexual dimorphism
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972016000300223&lng=en&tlng=en
work_keys_str_mv AT hugolfideleff malefemaledifferencesin6sulfatoxymelatoninexcretioninhypopituitarypatients
AT gabrielfideleff malefemaledifferencesin6sulfatoxymelatoninexcretioninhypopituitarypatients
AT hugorboquete malefemaledifferencesin6sulfatoxymelatoninexcretioninhypopituitarypatients
AT marthasuarez malefemaledifferencesin6sulfatoxymelatoninexcretioninhypopituitarypatients
AT miriamazaretzky malefemaledifferencesin6sulfatoxymelatoninexcretioninhypopituitarypatients
_version_ 1725087146119790592